½ÃÀ庸°í¼­
»óǰÄÚµå
1519401

¼¼°èÀÇ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀå º¸°í¼­ : Á¦Ç° À¯Çüº°, ÀÎÅÍÆäÀ̽ºº°, ¿¬·ÉÃþº°, ȯ±â ¸ðµåº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°(2024-2032³â)

Mechanical Ventilators Market Report by Product Type, Interface, Age Group, Mode of Ventilation, End-Use, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 138 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀå ±Ô¸ð´Â 2023³â 55¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2032³â±îÁö 79¾ï ´Þ·¯¿¡ À̸£°í, 2024-2032³â »çÀÌ¿¡ 4%ÀÇ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÁÖ·Î ¸¸¼º Æó»ö¼º ÆóÁúȯ(COPD)°ú È£Èí±â ÁúȯÀÇ À¯º´·ü »ó½Â, °íÇ÷¾Ð, ´ç´¢º´, ½ÉÇ÷°ü ÁúȯÀ» ¾Î°í Àִ ȯÀÚ Áõ°¡, ºñħ½ÀÀû¡¤ÈÞ´ë¿ë ±â°è½Ä ÀΰøÈ£Èí±â °³¹ß µîÀÇ Áö¼ÓÀûÀÎ ±â¼ú Áøº¸¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀå ºÐ¼® :

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ : COPD, õ½Ä, Æó·Å°ú °°Àº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ³ëÀÎ Àα¸ Áõ°¡´Â ±â°è½Ä Àΰø È£Èí±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡ ÀΰøÈ£Èí±âÀÇ È޴뼺, ¸ðµå, »ç¿ëÀÚ ÀÎÅÍÆäÀ̽ºÀÇ °³·® µîÀÇ ±â¼ú Çõ½ÅÀÌ ÁøÇàµÇ°í ÀÖ´Â °Íµµ ½ÃÀå È®´ë¸¦ ´õ¿í ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ : ÁÖ·Î ½ÅÈï °æÁ¦ ±¹°¡¿¡¼­ÀÇ ÀÇ·á ÁöÃâÀÇ Áõ´ë¿Í, ÀçÅÃÄ¡·á¶ó´Â »õ·Î¿î µ¿Çâ¿¡ ±âÀÎÇÏ´Â ÀçÅà Äɾî ȯ°æ¿¡¼­ÀÇ »ç¿ëÇϱ⠽±°í È޴뼺ÀÌ ¶Ù¾î³­ ±â±â¿¡ ¼ö¿ä Áõ°¡°¡ ÀÇ·á¿ë Àΰø È£Èí±â ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÚµ¿È­ ±â´É°ú ÃÖ÷´Ü ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãá Áö´ÉÇü º¯Á¾ÀÌ ³Î¸® »ç¿ëµÊ¿¡ µû¶ó ½ÃÀåÀº °è¼Ó ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ : ±â°è½Ä Àΰø È£Èí±â ½ÃÀå Á¡À¯À²ÀÇ ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷Àº Allied Healthcare Products, Air Liquide, Asahi Kasei, GE Healthcare Company, Hamilton Medical AG, Maquet GmbH & Co.KG(Gatenge), Medtronic Plc, Mindray Medical International Ltd., Philips Healthcare, ResMed, Smiths Group Plc, Vyaire Medical Inc. µîÀÌ ÀÖ½À´Ï´Ù.

Áö¸®Àû µ¿Çâ : ºÏ¹Ì´Â ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í °³ÀÎÀÇ ÀÇ·áºñ Áõ°¡·Î ÀÎÇØ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀå ¿¹ÃøÀÇ Áß¿äÇÑ °ßÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ À¯·´¿¡¼­´Â ÀÇ·áÀÇ Áú°ú ȯÀÚÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ½ÃÀåÀ» ´õ¿í Ȱ¼ºÈ­½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ³ëÀÎ Àα¸ Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤Àû ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­´Â °³ÀÎÀÇ ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç È£Èí±â Áúȯ¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°íÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

°úÁ¦¿Í ±âȸ: ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀå µ¿ÇâÀÇ ÁÖ¿ä °úÁ¦ Áß Çϳª´Â ÇʼöÀûÀÎ ÀÇ·á±â±â ºÎÁ·°ú ºñ¿ë°ú ½Ã°£ÀÌ ¸¹ÀÌ °É¸®´Â ÀåºñÀÇ Á¤±âÀûÀÎ À¯Áöº¸¼ö ¹× À¯Áöº¸¼öÀÔ´Ï´Ù. ±×·¯³ª ÀΰøÁö´É ¹× ¿ø°Ý ¸ð´ÏÅ͸µ°ú °°Àº ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü°ú ÀçÅÃÄ¡·áÀÇ »õ·Î¿î µ¿ÇâÀº ½ÃÀå¿¡ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

¼¼°èÀÇ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀå µ¿Çâ :

¸¸¼º È£Èí±â Áúȯ Áõ°¡

õ½Ä, ±Þ¼º Æó»ö¼º Æó Áúȯ ¹× Æó·ÅÀ» Æ÷ÇÔÇÑ ¸¸¼º È£Èí±â ÁúȯÀÇ Áõ·Ê Áõ°¡´Â ÁÖ·Î ±â°è½Ä Àΰø È£Èí±â ½ÃÀå Åë°è¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¼¼°è¿¡¼­ COVID-19 ÆÒµ¥¹ÍÀÌ ¹ß»ýÇÔ¿¡ µû¶ó »ç¸Á·ü, ÀÌȯÀ², ÀÇ·á ºñ¿ëÀÌ Áõ°¡ÇÏ¿© ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ´Ù¾çÇÑ ÀÇ·á ½Ã¼³Àº ÀÌ·¯ÇÑ È£Èí±â ÁúȯÀÇ Áõ·Ê¸¦ ÃÖ¼ÒÈ­Çϱâ À§ÇØ °ü¸® ´ëÃ¥°ú °¨¿° ¿¹¹æ¿¡ ¸Å¿ì ÈûÀ» ½ñ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, National Council on AgingÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é ºÒ±ÔÄ¢ÇÑ È£Èí°ú ³ú·ÎÀÇ »ê¼Ò °ø±Þ °¨¼Ò¸¦ Ư¡À¸·Î ÇÏ´Â Æó»ö¼º ¼ö¸é ¹«È£Èí ÁõÈıº(OSA)Àº ¹Ì±¹¿¡¼­ ¾à 3,900¸¸ ¸íÀÇ ¼ºÀÎÀÌ ¾Î°í ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î 9¾ï 3,600¸¸ ¸íÀÌ ÀÌȯµÇ°í ÀÖ´Ù°í ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹ ÆóÇùȸ¿¡ µû¸£¸é ¸¸¼ºÆó¼â¼º ÆóÁúȯ(COPD)Àº ¹Ì±¹¿¡¼­ Áúº´º° »çÀÎÀÇ 3À§ÀÔ´Ï´Ù. 1,640¸¸ ¸í ÀÌ»óÀÌ ¸¸¼º Æó»ö¼º Æó ÁúȯÀ¸·Î Áø´ÜµÇ¾ú½À´Ï´Ù.

±â¼ú Áøº¸

ÀΰøÈ£Èí±âÀÇ È޴뼺, ¸ðµå, »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º °³¼± µî ÇöÀç ÁøÇà ÁßÀÎ ±â¼úÀÇ ¹ßÀüÀº ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀåÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ÀçÅÃÄ¡·á¶ó´Â »õ·Î¿î µ¿Çâ¿¡ ÀÇÇØ °¡Á¤ ȯ°æ¿¡¼­ ÈÞ´ë °¡´ÉÇÏ°í »ç¿ëÇÏ±â Æí¸®ÇÑ ±â±âÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ, ¼¼°è ½ÃÀåÀ» Ȱ¼ºÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÀÚµ¿È­ ±â´É°ú °í±Þ ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãá ½º¸¶Æ®ÇÑ ±â°è½Ä ÀΰøÈ£Èí±âÀÇ Ã¤¿ëµµ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î Max Ventilator´Â °¡½À±â¿Í »ê¼Ò ¿ä¹ý ±â´ÉÀ» °®Ãá ºñħ½À¼º ÀΰøÈ£Èí±â¸¦ ¹ßÇ¥ÇÏ¿© ¼ºÀΰú ½Å»ý¾Æ ÀÇ·á¿¡ ´ëÇÑ ÀÀ¿ëÀÇ ´Ù¾ç¼ºÀ» º¸¿©ÁÖ¾ú½À´Ï´Ù. ¶ÇÇÑ Nihon Kohden OrangeMed, Inc.´Â ºñħ½ÀÀûÀÌ°í ºñ»ó½Ã È£Èí Áö¿øÀ» Á¦°øÇÏ´Â NKV-330 ÀΰøÈ£Èí±â ½Ã½ºÅÛÀÇ ¹Ì±¹ FDA ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù.

Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê

È£Èí±â Áúȯ°ú Á¶±â ¹ß°ß¡¤Ä¡·áÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇÑ °øÁßÀ§»ý Ä·ÆäÀÎ µî °¢±¹ÀÇ Á¤ºÎ±â°ü¿¡ ÀÇÇÑ ÀϺΠÁ¤Ã¥À̳ª ÀÌ´Ï¼ÅÆ¼ºêÀÇ °³½Ã´Â ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀå Àü¸Á¿¡ ±àÁ¤Àû ¿µÇâ Á¦°øÇÕ´Ï´Ù. ÀÌ¿¡ ´õÇØ ÃÖ½ÅÀÇ °³¼±µÈ ±â°è½Ä ÀΰøÈ£Èí±â ä¿ëÀ» À§ÇÑ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ÅõÀÚ Áõ°¡µµ ½ÃÀå È®´ë¸¦ ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶óÀÇ Áøº¸, ÀÇ·á Àü¹®°¡¸¦ À§ÇÑ ±³À° ÇÁ·Î±×·¥ ¹× ¼¼¹Ì³ª Áõ°¡°¡ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀåÀÇ ¼öÀÍÀ» ´õ¿í ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, CAIRE Inc.ÀÇ ÈÞ´ë¿ë »ê¼Ò ³óÃà±â FreeStyle Comfort´Â ÇÁ¶û½º¿Í µ¶ÀÏ¿¡¼­ º¸Çè »óȯÀÌ Çã°¡µÇ¾î ȯÀÚÀÇ Á¢±Ù¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ÀÌ È¸»ç´Â À̹ø Ãâ½Ã·Î »ê¼Ò ¿ä¹ý ¾ç½ÄÀÇ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇß½À´Ï´Ù. ¶ÇÇÑ CorVent MedicalÀº CE ¸¶Å©ÀÇ ½ÂÀÎÀ» ¹Þ¾Æ À¯·´¿¡¼­ RESPOND-19 Àΰø È£Èí±âÀÇ »ó¾÷Àû »ç¿ëÀ» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ »õ·Î¿î ½Ã½ºÅÛÀº »ç¿ëÇϱ⠽±°í ÁßÁõ ȯÀÚÀÇ È¯±â ´É·ÂÀ» À¯¿¬ÇÏ°Ô È®ÀåÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾úÀ¸¸ç, º´¿øÀº ±Þ¼º È£Èí °ï¶õ ÁõÈıº(ARDS)À¸·Î °íÅë¹Þ´Â ÁßÁõ ȯÀÚÀÇ Ä¡·á¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ±â°è½Ä Àΰø È£Èí±â ½ÃÀå ¼¼ºÐÈ­ :

IMARC GroupÀº ½ÃÀåÀÇ °¢ ºÎ¹®¿¡¼­ ÁÖ¿ä µ¿ÇâÀ» ºÐ¼®Çϰí 2024-2032³â±îÁö ¼¼°è, Áö¿ª ¹× ±¹°¡ Â÷¿øÀÇ ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù. Á¦Ç° À¯Çü, ÀÎÅÍÆäÀ̽º, ¿¬·É´ë, ȯ±â ¸ðµå, ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ½ÃÀåÀ» ºÐ·ùÇÕ´Ï´Ù.

Á¦Ç° À¯Çüº° ³»¿ª

ÁýÁß Ä¡·á¿ë Àΰø È£Èí±â

ÈÞ´ë¿ë/¿Ü·¡¿ë ÀΰøÈ£Èí±â

±âŸ

º» º¸°í¼­¿¡¼­´Â Á¦Ç° À¯Çüº°·Î ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ±¸ºÐ¡¤ºÐ¼®Çß½À´Ï´Ù. ¿©±â¿¡´Â ÁýÁß Ä¡·á¿ë ÀΰøÈ£Èí±â, ÈÞ´ë¿ë/¿Ü·¡¿ë ÀΰøÈ£Èí±â µîÀÌ Æ÷ÇԵ˴ϴÙ.

ÁýÁßÄ¡·á¿ë ÀΰøÈ£Èí±â´Â ÁýÁßÄ¡·á½Ç(ICU)°ú ÀÀ±Þ½Ç µîÀÇ Áß¿äÇÑ Äɾî ȯ°æ¿¡¼­ »ç¿ëÇϱâ À§ÇØ °³¹ßµÇ¾ú½À´Ï´Ù. ½ÉÇÑ È£Èí ºÎÀü ¹× ±âŸ ½É°¢ÇÑ »óÅÂÀÇ È¯ÀÚ¿¡°Ô °í±Þ È£Èí Áö¿øÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÑÆí, ÈÞ´ë¿ë/¿Ü·¡¿ë ÀΰøÈ£Èí±â´Â ÀçÅà Äɾî, ±¸±ÞÂ÷ ¹× ±âŸ ¿î¼Û ȯ°æ µî ±âÁ¸ º´¿ø ȯ°æ ÀÌ¿ÜÀÇ ¿ëµµ·Î ¼³°èµÇ¾ú½À´Ï´Ù. ÁýÁß Ä¡·á¿ëº¸´Ù ÀÛ°í °¡º±°í ¿î¹ÝÇϱ⠽±±â ¶§¹®¿¡ ´Ù¾çÇÑ Àå¼Ò¿¡¼­ »ç¿ëÇϱ⿡ ÀûÇÕÇÕ´Ï´Ù.

ÀÎÅÍÆäÀ̽ºº° ³»¿ª

ħ½ÀÀû ȯ±â

ºñħ½ÀÀû ÀΰøÈ£Èí

º» º¸°í¼­¿¡¼­´Â ÀÎÅÍÆäÀ̽ºº°·Î ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ±¸ºÐ¡¤ºÐ¼®Çß½À´Ï´Ù. ¿©±â¿¡´Â ħ½ÀÀû ȯ±â¿Í ºñħ½ÀÀû ȯ±â°¡ Æ÷ÇԵ˴ϴÙ.

ħ½ÀÀû Àΰø È£ÈíÀº ÀϹÝÀûÀ¸·Î ÀÔ°ú ÄÚ¿¡¼­(±â°ü ³» Æ©ºê) ¶Ç´Â °æºÎÀÇ ¼ö¼ú °³±¸ºÎ¿¡¼­(±â°ü Àý°³ Æ©ºê) ȯÀÚÀDZ⵵¿¡ Æ©ºê¸¦ »ðÀÔÇÕ´Ï´Ù. À̸¦ ÅëÇØ ÀΰøÈ£Èí±â´Â Æó¿¡ Á÷Á¢ °ø±â ¶Ç´Â »ê¼Ò¸¦ °ø±ÞÇÒ ¼ö ÀÖ½À´Ï´Ù. ħ½ÀÀû ÀΰøÈ£ÈíÀº ÀϹÝÀûÀ¸·Î ½ÉÇÑ È£ÈíºÎÀü ȯÀÚ³ª ÀÚ·ÂÀ¸·Î È£ÈíÇÒ ¼ö ¾ø´Â ȯÀÚ¿¡°Ô »ç¿ëµË´Ï´Ù. °Ô´Ù°¡, ºñħ½ÀÀû ÀΠȯ±â´Â ȯÀÚÀDZ⵵¿¡ Æ©ºê¸¦ »ðÀÔ ÇÒ Çʿ䰡 ¾ø½À´Ï´Ù. ´ë½Å ¸¶½ºÅ©¿Í À¯»çÇÑ ÀåÄ¡¸¦ »ç¿ëÇÏ¿© ȯÀÚÀÇ Æó¿¡ °ø±â¿Í »ê¼Ò¸¦ °ø±ÞÇÕ´Ï´Ù. ºñħ½ÀÀû ÀΰøÈ£ÈíÀº ½É°¢µµ°¡ ³·Àº È£ÈíºÎÀü ȯÀÚ³ª ÀÚ·ÂÀ¸·Î È£ÈíÀº °¡´ÉÇÏÁö¸¸ Ãß°¡ÀûÀÎ Áö¿øÀÌ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô »ç¿ëµÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.

¿¬·ÉÃþº° ³»¿ª

¼Ò¾Æ

¼ºÀÎ

³ëÀÎ

º» º¸°í¼­¿¡¼­´Â ¿¬·ÉÃþº°·Î ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ±¸ºÐ¡¤ºÐ¼®Çß½À´Ï´Ù. ¿©±â¿¡´Â ¾î¸°ÀÌ, ¼ºÀÎ ¹× ³ëÀÎÀÌ Æ÷ÇԵ˴ϴÙ.

¼Ò¾Æ¿ë ÀΰøÈ£Èí±â´Â ƯÈ÷ À¯¾Æ ¹× ¼Ò¾Æ¿ëÀ¸·Î °³¹ßµÇ¾ú½À´Ï´Ù. Å©±â°¡ ÀÛ°í ¼Ò¾Æ È¯ÀÚ Æ¯À¯ÀÇ È£Èí ¿ä±¸¿¡ ´ëÀÀÇÏ´Â ±â´ÉÀ» °®Ãß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡¿¡´Â Á¾Á¾ ÀÛÀº Æó¿Í±âµµ¿¡ ÀûÀýÇÑ ¼öÁØÀÇ Áö¿øÀ» Á¦°øÇϱâ À§ÇÑ Æ¯¼ö ¸ðµå¿Í ¼³Á¤ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡ ¼ºÀοë ÀΰøÈ£Èí±â´Â ¼ºÀΠȯÀÚ¿ëÀ¸·Î ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ¼Ò¾Æ¿ëº¸´Ù Å©°í °ß°íÇÏ¸ç ¼ºÀÎÀÇ È£Èí º¸Á¶¿¡ ÇÊ¿äÇÑ ³ôÀº Á¶¿ë·®°ú ¾Ð·ÂÀ» °ø±ÞÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÑÆí, ÀϹÝÀûÀ¸·Î ³ëÀÎÀÎ ³ëÀΠȯÀÚ´Â ³ëÈ­¿Í °ü·ÃµÈ È£Èí±â Áúȯ ¹× ÇÕº´ÁõÀ¸·Î ÀΰøÈ£Èí±â Áö¿øÀÌ ÇÊ¿äÇÒ ¼ö ÀÖ½À´Ï´Ù.

ȯ±â ¸ðµåº° ³»¿ª

º¹ÇÕ È¯±â ¸ðµå

üÀû ȯ±â ¸ðµå

°¡¾Ð ȯ±â ¸ðµå

±âŸ ȯ±â ¸ðµå

ÀÌ º¸°í¼­´Â ȯ±â ¸ðµå¸¦ »ó¼¼ÇÏ°Ô ºÐ·ùÇÏ°í ºÐ¼®ÇÕ´Ï´Ù. ¿©±â¿¡´Â º¹ÇÕ È¯±â ¸ðµå, üÀû ȯ±â ¸ðµå, ¾Ð·Â ȯ±â ¸ðµå ¹× ±âŸ ȯ±â ¸ðµå°¡ Æ÷ÇԵ˴ϴÙ.

µà¾ó ¸ðµå ¶Ç´Â ÇÏÀ̺긮µå ¸ðµå¶ó°íµµ ºÒ¸®´Â º¹ÇÕ È¯±â ¸ðµå´Â üÀû ȯ±â¿Í ¾Ð·Â ȯ±â Ãø¸éÀ» °áÇÕÇÑ °ÍÀÔ´Ï´Ù. ÀΰøÈ£Èí±â°¡ ¼³Á¤µÈ Á¶Àû¿ë·®À» À¯ÁöÇϱâ À§ÇØ Èí±â¾ÐÀ» Á¶ÀýÇÒ ¼ö ÀÖ¾î À¯¿¬Çϰí ÀûÀÀ¼ºÀÌ ³ôÀº ȯ±â°¡ °¡´ÉÇÕ´Ï´Ù. ¶ÇÇÑ, üÀû ȯ±â ¸ðµå¿¡¼­ Àΰø È£Èí±â´Â È£Èí ´ç ¼³Á¤µÈ Á¶¿ë·®À» ȯÀÚ¿¡°Ô °ø±ÞÇÕ´Ï´Ù. ÀÌ ¸ðµå´Â Æó ±ÔÁ¤ Áؼö°¡ Á¤»óÀΠȯÀÚ³ª ±Þ¼º È£Èí °ï¶õ ÁõÈıº(ARDS)°ú °°Àº Á¶¿ë·®ÀÇ Á¤È®ÇÑ Á¦¾î°¡ ÇÊ¿äÇÑ °æ¿ì¿¡ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ÀÌ ¿Ü¿¡µµ °¡¾Ð ȯ±â ¸ðµå¿¡¼­´Â ÀΰøÈ£Èí±â°¡ ¼³Á¤µÈ Èí±â¾ÐÀ» ȯÀÚ¿¡°Ô °ø±ÞÇϹǷΠȯÀÚÀÇ Æó ÄÄÇöóÀÌ¾ð½º¿Í ÀúÇ׿¡ µû¶ó Á¶¿ë·®À» º¸´Ù º¯È­½Ãų ¼ö ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº° ³»¿ª

º´¿ø ¹× Ŭ¸®´Ð

ÀçÅà °³È£

¿Ü·¡ ÄÉ¾î ¼¾ÅÍ

±âŸ

ÀÌ º¸°í¼­´Â ÃÖÁ¾ ¿ëµµº° ½ÃÀåÀÇ »ó¼¼ÇÑ ºÐ·ù¿Í ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¿©±â¿¡´Â º´¿ø ¹× Ŭ¸®´Ð, ÀçÅà Äɾî, ¿Ü·¡ ÄÉ¾î ¼¾ÅÍ µîÀÌ Æ÷ÇԵ˴ϴÙ.

º´¿øÀ̳ª Ŭ¸®´Ð¿¡¼­ ±â°è½Ä ÀΰøÈ£Èí±â´Â ÁýÁßÄ¡·á½Ç(ICU), ÀÀ±Þ½Ç, ¼ö¼ú½Ç, ÀÏ¹Ý º´µ¿¿¡¼­ ÀÌ¿ëµÇ¸ç ±Þ¼º È£Èí ºÎÀü, È£Èí °ï¶õ ¶Ç´Â º¸Á¶ ȯ±â¸¦ ÇÊ¿ä·Î ÇÏ´Â ±âŸ »óÅÂÀÇ È¯ÀÚ¸¦ Áö¿øÇÕ´Ï´Ù. ¶ÇÇÑ, ¸¸¼º Æó»ö¼º ÆóÁúȯ(COPD), ½Å°æ±ÙÀå¾Ö, ô¼ö ¼Õ»ó°ú °°Àº ¸¸¼º È£Èí±â Áúȯ ȯÀÚ¿¡°Ô Àå±âÀûÀΠȣÈí º¸Á¶¸¦ ¼öÇàÇϱâ À§ÇØ °¡Á¤ °£È£ ÇöÀå¿¡¼­ ÀÌ·¯ÇÑ Àåºñ¸¦ »ç¿ëÇÒ ¼öµµ ÀÖ½À´Ï´Ù. Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿Ü·¡Å¬¸®´ÐÀ̳ª ´çÀÏÄ¡±â¼ö¼ú¼¾Åͷεµ ¾Ë·ÁÁø ¿Ü·¡Áø·á¼¾ÅÍ¿¡¼­´Â ³»½Ã°æÃ³¸®³ª ¼Ò¼ö¼ú µî ÁøÁ¤À̳ª ¸¶Ã븦 ÇÊ¿ä·Î Çϴ óġ¸¦ ¹Þ´Â ȯÀÚ¿¡°Ô ±â°è½Ä ÀΰøÈ£Èí±â¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

Áö¿ªº° ºÐ¼®

ºÏ¹Ì

¹Ì±¹

ij³ª´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç

Áß±¹

ÀϺ»

Àεµ

Çѱ¹

È£ÁÖ

Àεµ³×½Ã¾Æ

±âŸ

À¯·´

µ¶ÀÏ

ÇÁ¶û½º

¿µ±¹

ÀÌÅ»¸®¾Æ

½ºÆäÀÎ

·¯½Ã¾Æ

±âŸ

¶óƾ¾Æ¸Þ¸®Ä«

ºê¶óÁú

¸ß½ÃÄÚ

±âŸ

Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

¶ÇÇÑ ºÏ¹Ì(¹Ì±¹, ij³ª´Ù), ¾Æ½Ã¾ÆÅÂÆò¾ç(Áß±¹, ÀϺ», Àεµ, Çѱ¹, È£ÁÖ, Àεµ³×½Ã¾Æ µî), À¯·´(µ¶ÀÏ, ÇÁ¶û½º, ¿µ±¹, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ·¯½Ã¾Æ, ±âŸ), ¶óƾ¾Æ¸Þ¸®Ä«(ºê¶óÁú, ¸ß½ÃÄÚ, ±âŸ), Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¸¦ Æ÷ÇÔÇÑ ÁÖ¿ä Áö¿ª ½ÃÀå¿¡ ´ëÇØ¼­µµ Á¾ÇÕÀûÀÎ ºÐ¼®À» ½Ç½ÃÇß½À´Ï´Ù.

ºÏ¹Ì´Â ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í °³ÀÎÀÇ ÀÇ·áºñ Áõ°¡·Î ÀÎÇØ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀå °³¿ä¿¡¼­ Áß¿äÇÑ Áö¿ªÀÌ µÇ¾ú½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ À¯·´¿¡¼­´Â ÀÇ·áÀÇ Áú°ú ȯÀÚÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ½ÃÀåÀ» ´õ¿í Ȱ¼ºÈ­½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ³ëÀÎ Àα¸ Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤Àû ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­´Â °³ÀÎÀÇ ÀÇ·áºñ ÁöÃâÀÌ ºÎÇ®¾î ¿À¸£°í ÀÖÀ¸¸ç È£Èí±â Áúȯ¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°íÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ Áúº´¿¹¹æ°ü¸®¼¾ÅÍ(CDC)°¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é COVID-19¿¡ ÀÇÇÑ Àü ÀÔ¿øÈ¯ÀÚ Áß 53% ÀÌ»óÀÌ ÁýÁßÄ¡·á½Ç¿¡ ÀÔ¿øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Critical Care¿¡ ½Ç¸° Silvio A. Namendys-Silva µîÀÇ Á¶»ç¿¡ µû¸£¸é ¸ß½ÃÄÚ¿¡¼­´Â ÀÔ¿ø ȯÀÚÀÇ ¾à 15.3%°¡ ħ½ÀÀû ±â°è ȯ±â(IMV)¸¦ ÇÊ¿ä·Î Çϰí, 70.8%ÀÇ È¯ÀÚ°¡ ICU Àܷ̿Πħ½À Àû ±â°è ȯ±â(IMV)¸¦ ¹Þ°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ¼¼°èÀÇ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ÃßÀÌÇØ, ÇâÈÄ ¾î¶»°Ô ÃßÀÌÇØ °¥ °ÍÀΰ¡?
  • ÁÖ¿ä Áö¿ª ½ÃÀåÀº ¾îµðÀԴϱî?
  • ¼¼°èÀÇ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâÀº?
  • Á¦Ç° À¯Çüº° ½ÃÀå ºÐ¼®Àº ¹«¾ùÀΰ¡?
  • ÀÎÅÍÆäÀ̽ºº° ½ÃÀå ºÐ¼®Àº ¹«¾ùÀΰ¡?
  • ¿¬·ÉÃþº° ½ÃÀå ºÐ¼®Àº ¹«¾ùÀΰ¡?
  • ÃÖÁ¾ ¿ëµµº° ½ÃÀå ºÐ¼®Àº?
  • ¾÷°èÀÇ ¹ë·ùüÀÎÀÇ ´Ù¾çÇÑ ´Ü°è´Â?
  • ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀΰú °úÁ¦´Â?
  • ¼¼°èÀÇ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀåÀÇ ±¸Á¶¿Í ÁÖ¿ä ÁøÃâ±â¾÷Àº?
  • ½ÃÀåÀÇ °æÀï Á¤µµ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå COVID-19 »ê¾÷¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦6Àå ¼¼°èÀÇ ±â°è½Ä ÀΰøÈ£Èí±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : Á¦Ç° À¯Çüº°

  • ÁýÁßÄ¡·á¿ë ÀΰøÈ£Èí±â
  • ÈÞ´ë¿ë/¿Ü·¡¿ë ÀΰøÈ£Èí±â
  • ±âŸ

Á¦8Àå ½ÃÀå ºÐ¼® : ÀÎÅÍÆäÀ̽ºº°

  • ħ½ÀÀû ȯ±â
  • ºñħ½ÀÀû ȯ±â

Á¦9Àå ½ÃÀå ºÐ¼® : ¿¬·ÉÃþº°

  • ¼Ò¾Æ
  • ¼ºÀÎ
  • °í·ÉÀÚ

Á¦10Àå ½ÃÀå ³»¿ª: ȯ±â ¸ðµåº°

  • º¹ÇÕ ¸ðµå
  • ¿ëÀû ¸ðµå
  • °¡¾Ð ¸ðµå
  • ±âŸ ȯ±â ¸ðµå

Á¦11Àå ½ÃÀå ³»¿ª: ÃÖÁ¾ ¿ëµµº°

  • º´¿ø ¹× Ŭ¸®´Ð
  • ÀçÅÃÄ¡·á
  • ¿Ü·¡ Áø·á ¼¾ÅÍ
  • ±âŸ

Á¦12Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦13Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦14Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦15Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Allied Healthcare Products
    • Air Liquide
    • Asahi Kasei
    • GE Healthcare Company
    • Hamilton Medical AG
    • Maquet GmbH & Co. KG(Gatenge)
    • Medtronic Plc
    • Mindray Medical International Ltd.
    • Philips Healthcare
    • ResMed
    • Smiths Group Plc
    • Vyaire Medical Inc.
JHS 24.07.31

The global mechanical ventilators market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4% during 2024-2032. The market is primarily driven by the rising prevalence of chronic obstructive pulmonary disease (COPD) and respiratory disorders, the elevating number of individuals suffering from hypertension, diabetes, and cardiovascular diseases, and the continuous technological advancements, such as the development of non-invasive and portable mechanical ventilators.

Global Mechanical Ventilators Market Analysis:

Major Market Drivers: The growing prevalence of several respiratory disorders, including COPD, asthma, and pneumonia and the rising geriatric population are catalyzing the mechanical ventilators market growth. Besides this, the ongoing innovations, such as the development of improved ventilator portability, modes, and user interfaces are further stimulating the market expansion.

Key Market Trends: The inflating healthcare expenditure, mainly in developing economies, and the escalating demand for user-friendly and portable devices in homecare settings, on account of the emerging trend of home-based medical care, are propelling the medical ventilators market demand. Moreover, the market is continuing to grow as a result of the widespread use of intelligent variations with automated functions and cutting-edge monitoring capabilities.

Competitive Landscape: Some of the major market players in the mechanical ventilators market share include Allied Healthcare Products, Air Liquide, Asahi Kasei, GE Healthcare Company, Hamilton Medical AG, Maquet GmbH & Co. KG (Gatenge), Medtronic Plc, Mindray Medical International Ltd., Philips Healthcare, ResMed, Smiths Group Plc, and Vyaire Medical Inc., among others.

Geographical Trends: North America represents a significant driver of the mechanical ventilators market forecast, owing to its advanced healthcare infrastructure and the inflating medical expenditures of individuals. Besides this, the increasing focus of Europe on healthcare quality and patient safety is further catalyzing the market forward. Moreover, in the Asia Pacific region, the rising aging population is positively influencing the market growth. Moreover, the inflating medical care spending by individuals in Latin America and Middle East and Africa and the increasing awareness towards respiratory diseases are augmenting the market expansion.

Challenges and Opportunities: One of the major challenges of the mechanical ventilators market trends include the shortage of essential medical equipment and regular maintenance and servicing of devices, which is costly and time-consuming. However, the continuous advances in technology, including AI and remote monitoring, and the emerging trend of home-healthcare are presenting significant growth opportunities for the market.

Global Mechanical Ventilators Market Trends:

Increasing Cases of Chronic Respiratory Conditions

The rising cases of chronic respiratory conditions, including asthma, acute obstructive pulmonary disease, and pneumonia are primarily driving the mechanical ventilators market statistics. Moreover, the outbreak of the COVID-19 pandemic across the globe had increased mortality, morbidity, and healthcare costs, which is propelling the market growth forward. Therefore, various medical facilities are focusing highly on control measures and infection prevention to minimize the cases of such respiratory diseases. For instance, the National Council on Aging data indicated that Obstructive Sleep Apnea (OSA), characterized by irregular breathing and reduced oxygen supply to the brain, affected about 39 million adults in the U.S. and an estimated 936 million globally. Additionally, as per the American Lung Association, chronic obstructive pulmonary disease (COPD) is the third leading cause of death by disease in the United States. More than 16.4 million people have been diagnosed with chronic obstructive pulmonary disease.

Technological Advancements

The ongoing technological advances, such as improved ventilator portability, modes, and user interfaces, are augmenting the mechanical ventilators market. Moreover, the growing popularity of portable and user-friendly devices in home settings, on account of the emerging trend of home-based medical care, is catalyzing the global market. Besides this, the introduction of smart mechanical ventilator variants with automated features and advanced monitoring capabilities is also positively influencing the market growth. For example, Max Ventilator introduced non-invasive ventilators featuring humidifiers and oxygen therapy capabilities, demonstrating versatility in applications for adult and neonatal care. Additionally, Nihon Kohden OrangeMed, Inc. received U.S. FDA clearance for the NKV-330 Ventilator System, which is non-invasive and provides respiratory support in emergencies.

Launch of Government Initiatives

The launch of several policies and initiatives by government bodies across countries, including public health campaigns to raise awareness about respiratory illnesses and the importance of early detection and treatment is positively influencing the mechanical ventilators market outlook. In addition to this, the inflating investments by regulatory authorities in research and development efforts for the introduction of the latest and improved mechanical ventilators are also propelling the market expansion. Moreover, the advancing healthcare infrastructures, along with the increasing number of training programs and seminars for medical professionals are further catalyzing the mechanical ventilators market revenue. For instance, CAIRE Inc.'s FreeStyle Comfort portable oxygen concentrator was authorized for reimbursement in France and Germany, enhancing patient access. The company extended its oxygen therapy modalities product portfolio through this launch. Furthermore, CorVent Medical received CE Mark approval and launched commercial use of its RESPOND-19 Ventilator in Europe. The novel system is designed for easy-to-use, flexible expansion of critical care ventilation capacity to allow hospitals to improve the treatment of critically ill patients suffering from acute respiratory distress syndrome (ARDS).

Global Mechanical Ventilators Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, interface, age group, mode of ventilation and end-use.

Breakup by Product Type:

Intensive Care Ventilators

Portable/Ambulatory Ventilators

Others

The report has provided a detailed breakup and analysis of the market based on the product type. This includes intensive care ventilators, portable/ambulatory ventilators, and others.

Intensive care ventilators are developed for usage in critical care settings, such as intensive care units (ICUs) and emergency departments. They are capable of offering an advanced respiratory support to patients with severe respiratory failure or other critical conditions. On the other hand, portable/ambulatory ventilators are designed for use outside of traditional hospital settings, including in-home care, ambulances, or other transport settings. They are smaller, lighter, and more portable than intensive care variants, making them suitable for use in various places.

Breakup by Interface:

Invasive Ventilation

Non-Invasive Ventilation

The report has provided a detailed breakup and analysis of the market based on the interface. This includes invasive ventilation and non-invasive ventilation.

Invasive ventilation typically comprises the insertion of a tube into the patient's airway, usually through the mouth or nose (endotracheal tube) or via a surgical opening in the neck (tracheostomy tube). This allows the ventilator to deliver air or oxygen directly into the lungs. Invasive ventilation is generally utilized for patients with severe respiratory failure or who are unable to breathe on their own. Moreover, non-invasive ventilation does not need the insertion of a tube into the airway of the individual. Instead, it uses a mask or similar device to deliver air or oxygen to the patient's lungs. Non-invasive ventilation is often used for patients with less severe respiratory failure or for patients who are able to breathe on their own but require the additional support.

Breakup by Age Group:

Pediatric

Adult

Geriatric

The report has provided a detailed breakup and analysis of the market based on the age group. This includes pediatric, adult, and geriatric.

Pediatric ventilators are specifically created for infants and children. They are smaller in size and have features that cater to the unique respiratory needs of pediatric patients. These devices often include specialized modes and settings to deliver the appropriate level of support for smaller lungs and airways. Besides this, adult ventilators are designed for use in adult patients. They are larger and more robust than pediatric derivatives and are capable of providing the higher tidal volumes and pressures demanded for adult respiratory support. On the other hand, geriatric patients, who are typically older adults, may require ventilator support, owing to age-related respiratory conditions or complications.

Breakup by Mode of Ventilation:

Combined Mode of Ventilation

Volume Mode of Ventilation

Pressure Mode of Ventilation

Other Mode of Ventilation

The report has provided a detailed breakup and analysis of the mode of ventilation. This includes combined mode of ventilation, volume mode of ventilation, pressure mode of ventilation, and other mode of ventilation.

Combined mode of ventilation, also referred to as dual or hybrid mode, combines the aspects of volume and pressure ventilation. It allows the ventilator to adjust the inspiratory pressure to maintain a set tidal volume, providing a more flexible and adaptable ventilation. Moreover, in volume mode of ventilation, the ventilator supplies a set tidal volume to the patient with each breath. This mode is commonly used in patients with normal lung compliance or when precise control over tidal volume is required, such as in acute respiratory distress syndrome (ARDS). Besides this, in pressure mode of ventilation, the ventilator delivers a set inspiratory pressure to the individual, allowing for a more variable tidal volume based on the lung compliance and resistance of the patient.

Breakup by End-Use:

Hospitals and Clinics

Home Care

Ambulatory Care Centers

Others

The report has provided a detailed breakup and analysis of the market based on the end-use. This includes hospitals and clinics, homecare, ambulatory care centers, and others.

In hospitals and clinics, mechanical ventilators are utilized in intensive care units (ICUs), emergency departments, operating rooms, and general wards to support patients with acute respiratory failure, respiratory distress, or other conditions that require assisted ventilation. Additionally, these devices are increasingly being used in homecare settings to provide long-term respiratory support to patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD), neuromuscular disorders, or spinal cord injuries. Furthermore, ambulatory care centers, also known as outpatient clinics or day surgery centers, may utilize mechanical ventilators for patients undergoing procedures that require sedation or anesthesia, including endoscopic procedures or minor surgeries.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

North America represents a significant region of the mechanical ventilators market overview, owing to its advanced healthcare infrastructure and the inflating medical expenditures of individuals. Besides this, the increasing focus of Europe on healthcare quality and patient safety is further catalyzing the market forward. Moreover, in the Asia Pacific region, the rising aging population is positively influencing the market growth. Besides this, the inflating medical care spending by individuals in Latin America and Middle East and Africa and the increasing awareness towards respiratory diseases are augmenting the market expansion. For instance, according to a report published by the Centers for Disease Control and Prevention (CDC), out of all the hospitalizations caused by COVID-19, over 53% of patients were admitted to the intensive care unit. Additionally, based on a research study by Silvio A. Namendys-Silva et al., published in Critical Care, in Mexico, about 15.3% of hospitalized patients require invasive mechanical ventilation (IMV), and 70.8% of patients receive invasive mechanical ventilation (IMV) outside the ICU.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the major market players in the Mechanical Ventilators industry include:

Allied Healthcare Products

Air Liquide

Asahi Kasei

GE Healthcare Company

Hamilton Medical AG

Maquet GmbH & Co. KG (Gatenge)

Medtronic Plc

Mindray Medical International Ltd.

Philips Healthcare

ResMed

Smiths Group Plc

Vyaire Medical Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Mechanical Ventilators Market Recent Developments:

February 2024: Getinge, a renowned global leader in medical technology, launched its latest innovation, the Servo-c mechanical ventilator, in India. The mechanical ventilator is crafted to offer lung-protective therapeutic tools, catering to the evolving demands of the healthcare landscape in the country.

October 2023: Concern Radio-Electronic Technologies completed the factory test of Mobivent Oxy mechanical ventilator, in Russia. Mobivent Oxy made by Urals Instrument-Making Plant is designed for high-flow oxygen therapy in children and adults. This is an adjunct treatment method that is suitable only for patients capable of spontaneous inhale breathing.

September 2023: The mechanical engineering professors at Villanova University in the U.S. received a patent to develop a new type of affordable mechanical ventilator called NovaVent. Built using widely accessible components, NovaVent offers continuous mandatory ventilation (CMV) for individuals who cannot breathe on their own.

Key Questions Answered in This Report:

  • How has the global mechanical ventilators market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global mechanical ventilators market?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the interface?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the mode of ventilation?
  • What is the breakup of the market based on the end-use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the global mechanical ventilators market and who are the key players?
  • What is the degree of competition in the market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 COVID-19 Impact on the Industry

6 Global Mechanical Ventilators Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Intensive Care Ventilators
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Portable/Ambulatory Ventilators
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Interface

  • 8.1 Invasive Ventilation
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-Invasive Ventilation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Age Group

  • 9.1 Pediatric
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Adult
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Geriatric
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Mode of Ventilation

  • 10.1 Combined Mode of Ventilation
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Volume Mode of Ventilation
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pressure Mode of Ventilation
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Other Mode of Ventilation
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by End-Use

  • 11.1 Hospitals and Clinics
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Home Care
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Ambulatory Care Centers
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Others
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Allied Healthcare Products
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Air Liquide
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Asahi Kasei
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 GE Healthcare Company
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Hamilton Medical AG
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Maquet GmbH & Co. KG (Gatenge)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Medtronic Plc
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Mindray Medical International Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Philips Healthcare
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 ResMed
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Smiths Group Plc
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Vyaire Medical Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦